BPA call for drug reference standards
Ended Awarded Last action
- Contract number
- W91YTZ25FA124
- Awardee
-
Cerilliant Corporation UEI JDDKSJ34EBZ7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $15,563
Award facts
- Contract value 100% obligated
- $15,562.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Meade, MD 20755, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $15,562.95 to Cerilliant Corporation for drug reference standards. This firm fixed-price call, issued October 1, 2023, with completion by June 6, 2025, supports the Defense Health Agency's drug testing and forensic toxicology operations at Fort Meade, Maryland. Cerilliant Corporation, a foreign-owned manufacturer headquartered in Round Rock, Texas, specializes in certified reference materials and chemical standards for pharmaceutical research, forensic analysis, and medical applications. The award carries no set-aside designation, reflecting Cerilliant's specialized capabilities in producing ISO-certified reference standards used for screening and confirmation testing of suspected drug use in service member blood, urine, and tissue samples.
This contract call falls under Cerilliant's $250,000 primary BPA with the Defense Health Agency, awarded October 1, 2023, and extending through September 30, 2028, for drug reference standards and related laboratory supplies. The company maintains an established federal contract portfolio with multiple indefinite delivery vehicles across defense and health agencies, including the Defense Health Agency, National Institutes of Health, Centers for Disease Control and Prevention, and Department of the Army Medical Command. Cerilliant's sustained relationships with these agencies demonstrate the company's critical role in supporting military medical readiness and forensic toxicology operations through the provision of high-quality certified reference materials meeting stringent ISO standards.
Quick answers
Who was awarded contract W91YTZ25FA124?
W91YTZ25FA124 was awarded to Cerilliant Corporation by Medical Command (Department of the Army) on October 1, 2023.
How much is contract W91YTZ25FA124 worth?
The government has obligated $15,563 on W91YTZ25FA124.
Which agency awarded contract W91YTZ25FA124?
Medical Command (Department of the Army) awarded W91YTZ25FA124, with funding from Defense Health Agency (Department of Defense).
Is contract W91YTZ25FA124 an order under another contract?
Yes. W91YTZ25FA124 is a BPA call under W91YTZ23A0014, a blanket purchase agreement.
Was contract W91YTZ25FA124 competed?
The extent of competition for W91YTZ25FA124 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award